CELU
Celularity Inc. Class A Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Celularity (CELU) Stock: Buy, Sell, or Hold?
$0.46
0.00 (-1.05%)
▼
5d:
-26.52%
30d:
-55.9%
90d:
-40.24%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Nov 20, 2026
Protect CELU Gains
Updated Nov 20, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (67%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$0.60 – $1.12
Position: OVERSOLD
Wall Street Target
$2.50
+440.0% upside
Options IV & Volume
20th pct IV
HIGH volume confirmation
Support / Resistance
$0.42 / $0.80
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: CELU is down 26.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When CELU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CELU is currently trading at $0.46, which is considered oversold relative to its 30-day fair value range of $0.60 to $1.12.
Technical Outlook: Technically, CELU is showing sideways momentum. Immediate support is located at $0.42, while resistance sits at $0.80.
Market Sentiment: CELU scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $2.50 (+440.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CELU is showing sideways momentum. Immediate support is located at $0.42, while resistance sits at $0.80.
Market Sentiment: CELU scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $2.50 (+440.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.60 -
$1.12
Company Quality Score
45/100
(HOLD)
Options IV Signal
20th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
66.7%
Trading Range & Key Levels
30-Day Trading Range
$0.60 -
$1.12
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.15
(33.3%)
Support Level
$0.42
Resistance Level
$0.80
Current Trend
Sideways
Technical data as of
Nov 20, 2026
Protect Your Profits
Holding CELU? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanInstitutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Phase & Gamma Walls
BREAKDOWN
Days in Phase:
60d (53% conf)
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 20th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 440.0% below Wall St target ($2.50)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Wall Street Target
$2.50
(+440.0%)
Revenue Growth (YoY)
-5.3%
Earnings Growth (YoY)
-61.3%
Profit Margin
-245.7%
Share CELU Analysis
Share this live CELU analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CELU)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
Retail Stream Volume
1 msgs
24h retail stream
Last Tracked
Nov 19, 2026
Daily AI digest
AI Retail Discussion Summary:
Vesalius Longevity Labs appoints Dr. Peter Diamandis to its board of directors, a well-known longevity entrepreneur.
Aggregated from r/wallstreetbets, r/stocks & retail trader streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 21, 2026 7:03 PM ET
Data refreshes hourly during market hours. Next update: 8:03 PM
Data refreshes hourly during market hours. Next update: 8:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 47 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 55 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$106 | 62 BUY |
Advanced CELU Option Strategies
Professional options setups generated by AI based on today's CELU price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CELU Research Pages
CELU Technical Chart
CELU Price Prediction
CELU Intrinsic Value DCF
CELU Earnings Date
CELU Investment Advisor
CELU Fair Price Analyzer
CELU Target Price Playground
CELU 5-Day Options Simulator
CELU LEAP Simulator
CELU Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
CELU Options Chain
CELU Options Advisor
CELU Options Analysis
CELU Competitors
Part B: Tradestie Flagship Market Scanners